The potential impact of drug transporters on nucleoside-analog-based antiviral chemotherapy
- 30 April 2004
- journal article
- review article
- Published by Elsevier in Antiviral Research
- Vol. 62 (1), 1-7
- https://doi.org/10.1016/j.antiviral.2003.11.002
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Differential Modulation of the Human Liver Conjugate Transporters MRP2 and MRP3 by Bile Acids and Organic AnionsJournal of Biological Chemistry, 2003
- Therapeutic and biological importance of getting nucleotides out of cells: a case for the ABC transporters, MRP4 and 5Advanced Drug Delivery Reviews, 2002
- Expression of MRP4 Confers Resistance to Ganciclovir and Compromises Bystander Cell KillingJournal of Biological Chemistry, 2002
- Mammalian ABC Transporters in Health and DiseaseAnnual Review of Biochemistry, 2002
- MRP9, an unusual truncated member of the ABC transporter superfamily, is highly expressed in breast cancerProceedings of the National Academy of Sciences, 2002
- MRP8, A New Member of ABC Transporter Superfamily, Identified by EST Database Mining and Gene Prediction Program, Is Highly Expressed in Breast CancerMolecular Medicine, 2001
- Interactions of the Human Multidrug Resistance Proteins MRP1 and MRP2 with Organic AnionsMolecular Pharmacology, 2000
- The multidrug resistance protein familyBiochimica et Biophysica Acta (BBA) - Biomembranes, 1999
- Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives.Proceedings of the National Academy of Sciences, 1996
- Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent anti-human immunodeficiency virus compound.Proceedings of the National Academy of Sciences, 1991